Tag #Medicinal Cannabis

Showing 1 to 4 of 4 results

smh.com.au

🌐 85% Global Worthiness

Jul 31, 22:14

Montu Faces Scrutiny Over High-Volume Medicinal Cannabis Prescriptions

Australia's largest medicinal cannabis company, Montu, is under scrutiny for high-volume prescriptions; leaked data reveals 8 doctors issued 245,109 scripts in two years, prompting investigations and calls for broader cannabis reform to address potential conflicts of interest and ensure patient safe...

Montu Faces Scrutiny Over High-Volume Medicinal Cannabis Prescriptions

Australia's largest medicinal cannabis company, Montu, is under scrutiny for high-volume prescriptions; leaked data reveals 8 doctors issued 245,109 scripts in two years, prompting investigations and calls for broader cannabis reform to address potential conflicts of interest and ensure patient safe...

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of Montu's high-volume medicinal cannabis prescriptions, and how does this impact patient safety and industry regulation?

Montu, Australia's largest medicinal cannabis company, faced criticism for a doctor issuing 72,000 prescriptions (27,231 treatment plans) in two years. The company defended this, citing adherence to regulations and a 20-minute nurse consultation per patient. However, leaked documents revealed 8 doctors issued 245,109 prescriptions, raising concerns about over-prescribing and potential conflicts of interest.

smh.com.au

🌐 75% Global Worthiness

Apr 3, 10:12

NSW Drug Summit Recommends Reduced Sentences, Harm Reduction Measures

The 2024 NSW Drug Summit, concluding Thursday after four days in Sydney, Griffith, and Lismore, recommended halving maximum sentences for minor drug offenses, ending drug dog use and strip searches at music festivals, and allowing a medical defense for driving under prescribed cannabis.

NSW Drug Summit Recommends Reduced Sentences, Harm Reduction Measures

The 2024 NSW Drug Summit, concluding Thursday after four days in Sydney, Griffith, and Lismore, recommended halving maximum sentences for minor drug offenses, ending drug dog use and strip searches at music festivals, and allowing a medical defense for driving under prescribed cannabis.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the potential long-term impacts of the summit's recommendations, and what challenges might arise in their implementation?

The long-term impact of these recommendations could include a decrease in drug-related arrests and convictions, potentially freeing up resources for treatment and prevention programs. However, the report's avoidance of full decriminalization may limit its effectiveness in addressing the root causes of drug use. Future policy debates will likely center on the balance between public safety and individual rights.

smh.com.au

🌐 85% Global Worthiness

Jul 28, 01:11

Australian Medicinal Cannabis Company Under Scrutiny for High-Volume Prescribing

A doctor at Australia's largest medicinal cannabis company, Montu, issued 72,000 prescriptions to 10,000 patients in two years, prompting concerns about unsafe prescribing practices and leading to investigations by federal health authorities; Montu initially denied but later confirmed the figures.

Australian Medicinal Cannabis Company Under Scrutiny for High-Volume Prescribing

A doctor at Australia's largest medicinal cannabis company, Montu, issued 72,000 prescriptions to 10,000 patients in two years, prompting concerns about unsafe prescribing practices and leading to investigations by federal health authorities; Montu initially denied but later confirmed the figures.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of a single doctor at Australia's largest medicinal cannabis company issuing 72,000 prescriptions in two years?

A single doctor at Australia's Montu, the country's largest medicinal cannabis company, issued 72,000 prescriptions to 10,000 patients in two years. This raised concerns about potentially unsafe prescribing practices within the booming telehealth medicinal cannabis industry, prompting investigations by federal health authorities. The company initially denied the figures but later confirmed them, attributing it to an outlier doctor.

dailymail.co.uk

🌐 75% Global Worthiness

Feb 4, 16:11

UK's First Legal Cannabis Factory Opens, Addressing Medicinal Supply Shortages

Derbyshire-based Dalgety opened the UK's first legal cannabis factory, a £10 million facility protected by ex-military guards, addressing the shortage of domestically produced medicinal cannabis and aiming to provide patients with high-quality, timely supplies within one month of harvest.

UK's First Legal Cannabis Factory Opens, Addressing Medicinal Supply Shortages

Derbyshire-based Dalgety opened the UK's first legal cannabis factory, a £10 million facility protected by ex-military guards, addressing the shortage of domestically produced medicinal cannabis and aiming to provide patients with high-quality, timely supplies within one month of harvest.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What challenges does the UK medical cannabis industry face in terms of regulation and supply chain?

The opening highlights the burgeoning UK medical cannabis market, valued at £2.3 billion in 2022, yet hampered by licensing hurdles and supply chain issues. Dalgety's four-and-a-half-year licensing process underscores the regulatory complexities, contributing to the persistent illegal market. The factory's advanced growing methods and focus on quality aim to alleviate these problems by providing a reliable, domestically sourced supply.

Showing 1 to 4 of 4 results